Kinetoplastid RNA editing
动质体RNA编辑
基本信息
- 批准号:10200087
- 负责人:
- 金额:$ 35.04万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-07-13 至 2024-06-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAffinity ChromatographyAntibodiesBindingBioenergeticsBioinformaticsBlood CirculationCo-ImmunoprecipitationsComplexDataDefectDevelopmentDevelopmental ProcessDiscriminationEssential GenesFoundationsFutureGenerationsGoalsGrowthGuide RNAHeterogeneityHigh-Throughput Nucleotide SequencingHoloenzymesHumanImmunoprecipitationIn VitroInsect VectorsInsectaKnowledgeLaboratoriesLeftLengthLifeLife Cycle StagesMass Spectrum AnalysisMediator of activation proteinMedicalMessenger RNAMitochondriaMitochondrial ProteinsModelingMolecularNucleotidesOrganismParasitesPatternPlayPoly APositioning AttributeProcessProteinsPublishingRNARNA BindingRNA EditingRNA InterferenceRegulationRegulator GenesResolutionRibonucleoproteinsRoleSiteSystemTailTechnologyTestingTrypanosomaTrypanosoma brucei bruceiUridineVirulenceWorkbioinformatics tooldrug developmentenzyme mechanisminnovationinsertion/deletion mutationinsightknock-downmitochondrial messenger RNAmutantnovelprotein complexprotein functionprotein protein interactionrecruitscaffoldtooltraffickingtranscriptome
项目摘要
RNA editing in kinetoplastid parasites entails massive remodeling of mitochondrial mRNAs by
posttranscriptional insertion and deletion of uridine (U) residues to generate mRNAs encoding proteins
involved in parasite bioenergetics. U insertion/deletion RNA editing is unique to kinetoplastids and essential for
T. brucei survival and virulence. The RNA editing holoenzyme comprises two subcomplexes: RECC (RNA
Editing Core Complex) and RESC (RNA Editing Substrate Binding Complex). Trans-acting guide RNAs
(gRNAs) direct U insertion/deletion, acting sequentially such that editing proceeds 3' to 5' along an mRNA.
RECC contains the editing enzymes, and the mechanisms by which RECC catalyzes U insertion/deletion at a
single editing site have been extensively studied. More recently, RESC has emerged as the scaffold for editing
and a coordinator of interactions between mRNAs, gRNAs, and RECC, although the mechanisms by which it
accomplishes these tasks are essentially unknown. Adding even more complexity, editing of specific mRNAs is
differentially regulated between human bloodstream form (BF) and insect vector procyclic form (PF) parasites.
The mechanism(s) of developmental regulation, and the precise point(s) in the life cycle at which they are
effected, remain entirely mysterious. The goals of this application are to (1) delineate the roles of distinct
components of RESC and a novel RESC-related complex in gRNA trafficking and utilization, and (2) to define
aspects of the editing process that serve as control points for stage specific regulation during the T. brucei life
cycle. To accomplish these goals, we developed an innovative and powerful bioinformatic tool (HTS/TREAT)
that permits us to now examine the mitochondrial transcriptome at single nucleotide resolution, and group
partially edited mRNA intermediates in ways that illuminate specific aspects of gRNA usage. Combining this
bioinformatic approach with RNA immunoprecipitation and protein-protein interaction studies, we will define the
mechanisms by which specific RESC proteins function, correlate these to RESC heterogeneity and dynamic
interactions, and elucidate the steps in the editing process that are developmentally controlled. We will also
take advantage of recent technology that permits generation of substantial numbers of insect metacyclic form
(MF) T. brucei, a largely unexplored intermediate between PF and BF. Using HTS/TREAT, we will define the
patterns of RNA editing in MFs, and reveal whether BF RNA editing patterns for some or all mRNAs emerge in
MFs, providing insight into the temporal control of RNA editing during T. brucei development. The proposed
studies address several important gaps in knowledge regarding the essential kinetoplastid RNA editing
process. Moreover, this work may help lay the foundation for future drug development and provide important
insights into ribonucleoprotein complex function in higher organisms.
动质体寄生虫中的RNA编辑导致线粒体mRNAs的大规模重塑,
尿苷(U)残基的转录后插入和缺失以产生编码蛋白质的mRNA
与寄生虫生物能量学有关U插入/缺失RNA编辑是动质体所特有的,并且对于
T.布鲁氏菌存活率和毒力。RNA编辑全酶包括两个亚复合物:RECC(RNA
编辑核心复合物(RNA Editing Core Complex)和RESC(RNA Editing Substrate Binding Complex)。反式作用向导RNA
(gRNA)指导U插入/缺失,顺序地起作用,使得编辑沿着mRNA从3'沿着5'进行。
RECC含有编辑酶,以及RECC催化U插入/缺失的机制。
单个编辑位点已被广泛研究。最近,RESC已经成为编辑的支架
以及mRNA、gRNA和RECC之间相互作用的协调者,尽管它的机制是
完成这些任务基本上是未知的。更复杂的是,特定mRNA的编辑是
在人类血流形式(BF)和昆虫媒介原环形式(PF)寄生虫之间差异调节。
发育调节的机制,以及它们在生命周期中的精确点
影响,保持完全神秘。本应用程序的目标是(1)描述不同的
RESC的组成部分和一种新的RESC相关复合物在gRNA运输和利用,和(2)定义
编辑过程的各个方面,作为T.布鲁氏菌病
周期为了实现这些目标,我们开发了一个创新的和强大的生物信息学工具(HTS/TREAT)
这使得我们现在可以在单核苷酸分辨率下检查线粒体转录组,
部分编辑的mRNA中间体,以阐明gRNA使用的特定方面。组合该
生物信息学方法与RNA免疫沉淀和蛋白质-蛋白质相互作用的研究,我们将定义
特异性RESC蛋白发挥功能的机制,将这些与RESC异质性和动态
互动,并阐明在编辑过程中的步骤,是发展控制。我们还将
利用允许产生大量昆虫元环形式的最新技术
(MF)T.布氏杆菌,PF和BF之间的一个基本上未开发的中间体。使用HTS/TREAT,我们将定义
在MF中的RNA编辑模式,并揭示是否BF RNA编辑模式的一些或所有的mRNA出现在
MF,提供了对T.布氏发展拟议
研究解决了关于基本动质体RNA编辑知识的几个重要空白,
过程此外,这项工作可能有助于为未来的药物开发奠定基础,
深入了解核糖核蛋白复合体在高等生物中的功能。
项目成果
期刊论文数量(6)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Developmental dynamics of mitochondrial mRNA abundance and editing reveal roles for temperature and the differentiation-repressive kinase RDK1 in cytochrome oxidase subunit II mRNA editing.
- DOI:10.1128/mbio.01854-23
- 发表时间:2023-10-31
- 期刊:
- 影响因子:6.4
- 作者:
- 通讯作者:
High throughput sequencing revolution reveals conserved fundamentals of U-indel editing.
高通量测序革命揭示了 U-indel 编辑的保守基础。
- DOI:10.1002/wrna.1487
- 发表时间:2018
- 期刊:
- 影响因子:0
- 作者:Zimmer,SaraL;Simpson,RachelM;Read,LaurieK
- 通讯作者:Read,LaurieK
Trypanosome RNAEditing Substrate Binding Complex integrity and function depends on the upstream action of RESC10.
- DOI:10.1093/nar/gkab129
- 发表时间:2021-04-06
- 期刊:
- 影响因子:14.9
- 作者:Dubey AP;Tylec BL;McAdams NM;Sortino K;Read LK
- 通讯作者:Read LK
Intrinsic and regulated properties of minimally edited trypanosome mRNAs.
最低限度编辑的锥虫 mRNA 的内在和调控特性。
- DOI:10.1093/nar/gkz012
- 发表时间:2019
- 期刊:
- 影响因子:14.9
- 作者:Tylec,BriannaL;Simpson,RachelM;Kirby,LauraE;Chen,Runpu;Sun,Yijun;Koslowsky,DonnaJ;Read,LaurieK
- 通讯作者:Read,LaurieK
Developmental regulation of edited CYb and COIII mitochondrial mRNAs is achieved by distinct mechanisms in Trypanosoma brucei.
布氏锥虫中编辑的 CYb 和 COIII 线粒体 mRNA 的发育调节是通过不同的机制实现的。
- DOI:10.1093/nar/gkaa641
- 发表时间:2020
- 期刊:
- 影响因子:14.9
- 作者:SmithJr,JosephT;Doleželová,Eva;Tylec,Brianna;Bard,JonathanE;Chen,Runpu;Sun,Yijun;Zíková,Alena;Read,LaurieK
- 通讯作者:Read,LaurieK
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Laurie K. Read其他文献
Laurie K. Read的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Laurie K. Read', 18)}}的其他基金
Alternative polyadenylation regulation in Trypanosoma brucei
布氏锥虫的替代多腺苷酸化调控
- 批准号:
10584834 - 财政年份:2022
- 资助金额:
$ 35.04万 - 项目类别:
Function and regulation of the essential RNA binding protein, DRBD18
必需 RNA 结合蛋白 DRBD18 的功能和调节
- 批准号:
10649589 - 财政年份:2019
- 资助金额:
$ 35.04万 - 项目类别:
Function and regulation of the essential RNA binding protein, DRBD18
必需 RNA 结合蛋白 DRBD18 的功能和调节
- 批准号:
9811587 - 财政年份:2019
- 资助金额:
$ 35.04万 - 项目类别:
Function and regulation of the essential RNA binding protein, DRBD18
必需 RNA 结合蛋白 DRBD18 的功能和调节
- 批准号:
10404501 - 财政年份:2019
- 资助金额:
$ 35.04万 - 项目类别:
Posttranslational modification of the regulatory RNA binding protein, ZFP3
调节性 RNA 结合蛋白 ZFP3 的翻译后修饰
- 批准号:
9163318 - 财政年份:2016
- 资助金额:
$ 35.04万 - 项目类别:
Posttranslational modification of the regulatory RNA binding protein, ZFP3
调节性 RNA 结合蛋白 ZFP3 的翻译后修饰
- 批准号:
9298582 - 财政年份:2016
- 资助金额:
$ 35.04万 - 项目类别:
Cis- and trans-acting factors in mitochondrial RNA decay
线粒体 RNA 衰减中的顺式和反式作用因子
- 批准号:
7798222 - 财政年份:2008
- 资助金额:
$ 35.04万 - 项目类别:
Cis- and trans-acting factors in mitochondrial RNA decay
线粒体 RNA 衰减中的顺式和反式作用因子
- 批准号:
7617872 - 财政年份:2008
- 资助金额:
$ 35.04万 - 项目类别:
Cis- and trans-acting factors in mitochondrial RNA decay
线粒体 RNA 衰减中的顺式和反式作用因子
- 批准号:
7433401 - 财政年份:2008
- 资助金额:
$ 35.04万 - 项目类别:
Cis- and trans-acting factors in mitochondrial RNA decay
线粒体 RNA 衰减中的顺式和反式作用因子
- 批准号:
8053468 - 财政年份:2008
- 资助金额:
$ 35.04万 - 项目类别:
相似海外基金
Cellular membrane affinity chromatography kit for drug discovery
用于药物发现的细胞膜亲和层析试剂盒
- 批准号:
10506915 - 财政年份:2021
- 资助金额:
$ 35.04万 - 项目类别:
Cellular membrane affinity chromatography kit for drug discovery
用于药物发现的细胞膜亲和层析试剂盒
- 批准号:
10325006 - 财政年份:2021
- 资助金额:
$ 35.04万 - 项目类别:
SBIR Phase I: A New Class of Immobilized Metal Affinity Chromatography Resins
SBIR 第一阶段:一类新型固定金属亲和色谱树脂
- 批准号:
1746198 - 财政年份:2018
- 资助金额:
$ 35.04万 - 项目类别:
Standard Grant
Marine speciation of nickel using immobilized nickel affinity chromatography
使用固定镍亲和色谱法测定镍的海洋形态
- 批准号:
512537-2017 - 财政年份:2017
- 资助金额:
$ 35.04万 - 项目类别:
University Undergraduate Student Research Awards
I-Corps: Commercialization of Immobilized Metal Affinity Chromatography Resins Based on Nanomaterials
I-Corps:基于纳米材料的固定化金属亲和层析树脂的商业化
- 批准号:
1404605 - 财政年份:2014
- 资助金额:
$ 35.04万 - 项目类别:
Standard Grant
Antibody Purification via Affinity Chromatography that Utilizes the Unconventional Nucleotide Binding Site
利用非常规核苷酸结合位点通过亲和色谱法纯化抗体
- 批准号:
1263713 - 财政年份:2013
- 资助金额:
$ 35.04万 - 项目类别:
Continuing Grant
Development of multivalent DNA network based affinity chromatography diagnostics for isolating circulating tumour cells
开发基于多价 DNA 网络的亲和色谱诊断法,用于分离循环肿瘤细胞
- 批准号:
425749-2012 - 财政年份:2012
- 资助金额:
$ 35.04万 - 项目类别:
Postgraduate Scholarships - Master's
Next-Generation Affinity Chromatography with PEGylated Ligands
使用聚乙二醇化配体的新一代亲和色谱法
- 批准号:
1159886 - 财政年份:2012
- 资助金额:
$ 35.04万 - 项目类别:
Standard Grant
Immobilized zirconium ion affinity chromatography for specific enrichment of phosphoproteins
用于磷蛋白特异性富集的固定化锆离子亲和层析
- 批准号:
19560760 - 财政年份:2007
- 资助金额:
$ 35.04万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Accelerating drug discovery using frontal affinity chromatography/mass spectrometry
使用正面亲和色谱/质谱加速药物发现
- 批准号:
234753-2000 - 财政年份:2003
- 资助金额:
$ 35.04万 - 项目类别:
Collaborative Research and Development Grants